Health
Chronicle Pharmabiz
VIROCON 2025 to weigh on viral threats
VIROCON 2025, which will be held from December 8 to 10, 2025 in Pune, will deliberate on current and emerging viral threats, spanning human, animal and plant health under the One Health framework.
1 min |
October 16, 2025
Chronicle Pharmabiz
PCI restores permission to 42 institutions in Maharashtra
THE Pharmacy Council of India (PCI) has restored permission to 42 pharmacy institutions in Maharashtra to offer admission to the relevant courses for the academic year 2025-26. These were among the 89 institutions the Council had earlier denied permission to conduct admission for first year in B. Pharm and D. Pharm courses for the academic year, based on a report from the Government of Maharashtra.
2 min |
October 16, 2025
Chronicle Pharmabiz
TNPDA vows action against manufacturers violating pricing norms
THE annual general body meeting of the Tamil Nadu Pharmaceutical Distributors Association (TNPDA), held last week in Kochi, proved to be a critical session focused on the existential threats facing the sector.
1 min |
October 16, 2025
Chronicle Pharmabiz
Survey reveals cough syrups dispensed in Maharashtra without valid prescription
IN an independent survey conducted by the All Food and Drug Licence Holders Foundation (AFDLHF) over the past one week has revealed that cough syrups are being dispensed in retail pharmacies across Mumbai and Maharashtra without a doctor's prescription.
1 min |
October 16, 2025
Chronicle Pharmabiz
analytica Lab India concludes on record-breaking note
HYDERABAD witnessed a remarkable convergence of science, technology, and business as analytica Lab India and Pharma Pro&Pack Expo 2025 unfolded at the HITEX Exhibition Centre.
3 min |
October 16, 2025
Chronicle Pharmabiz
WHO issues alert on three cough syrups in India
THE World Health Organisation (WHO) has raised an alert against three liquid medicines, used to address common cold, flu or cough, manufactured in India as substandard, advising the national regulatory authorities and law enforcement authorities to immediately notify if these products are detected in their country.
2 min |
October 16, 2025
Chronicle Pharmabiz
Strategic resilience: Indian CDMOs redefine global pharma
FOR decades, India's pharmaceutical sector was defined by its role as the world's reliable manufacturer of low-cost medicines.
3 min |
October 16, 2025
Chronicle Pharmabiz
Biocon gets US FDA nod for Bosaya & Aukelso
BIOCON Biologics, a fully integrated global biosimilars company and subsidiary of Biocon has received the US Food and Drug Administration (FDA) approval for Bosaya (denosumab-kyqq) 60 mg/mL injection for subcutaneous use in a single dose prefilled syringe (PFS), and Aukelso (denosumab-kyqq) 120 mg/1.7 mL (70 mg/mL) injection for subcutaneous use in a single-dose vial, biosimilars of Prolia and Xgeva respectively.
1 min |
September 25, 2025
Chronicle Pharmabiz
Centre to appoint 49 drug inspectors in CDSCO
THE Union Ministry of Health and Family Welfare has notified recruitment of 49 drug inspectors under the Central Drugs Standard Control Organisation (CDSCO), as part of strengthening the organisation's operations to regulate and monitor the drugs and pharmaceutical industry and market in the country.
1 min |
September 25, 2025
Chronicle Pharmabiz
Cold Chain Community to hold conference in Ahmedabad
IN order to create new opportunities in the pharmaceutical cold chain sector, Cold Chain Community, a knowledge-based business platform powered by the National Accreditation Body for Cold Chain Management (NAB-CCM), will hold one-day conference on November 4, 2025 in Ahmedabad.
1 min |
September 25, 2025
Chronicle Pharmabiz
HC appoints team to conduct inspection on Palamur Bio's facility
THE Delhi High Court (HC) has appointed a three-member inspection team to conduct fresh inspection at the facility of Telan-gana-based preclinical contract research organisation Palamur Biosciences in connection with the allegations raised by the People for the Ethical Treatment of Animals India (PETA India) pertaining to abuse and neglect of animals while carrying out experimentation.
2 min |
September 25, 2025
Chronicle Pharmabiz
Merck gets 2 positive opinions from CHMP for Keytruda
MERCK, known as MSD outside of the US and Canada, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted two positive opinions for Keytruda (pembrolizumab), Merck's anti-PD-1 therapy. One recommends approval of a new subcutaneous (SC) route of administration and a new pharmaceutical form (solution for injection) for Keytruda (pembrolizumab), which if approved would be marketed in the European Union (EU) as Keytruda SC.
1 min |
September 25, 2025
Chronicle Pharmabiz
Aptar's Enbumyst receives US FDA nod
APTAR Pharma, a global leader in drug delivery and active material science solutions and services, announced that its unidose liquid system is the delivery system for the recent US FDA-approved Enbumyst (Bumetanide nasal spray) 0.5mg by Corstasis Therapeutics.
1 min |
September 25, 2025
Chronicle Pharmabiz
Health insurance faces headwinds of escalating medical inflation
HEALTH insurance industry is entering a period of financial stress, driven by two critical factors.
2 min |
September 25, 2025
Chronicle Pharmabiz
NABL, Ladakh Univ team up to enhance lab capabilities
THE National Accreditation Board for Testing and Calibration Laboratories (NABL) and the University of Ladakh have partnered to enhance testing laboratory capabilities, research, and skill development in Ladakh.
1 min |
September 25, 2025
Chronicle Pharmabiz
AICDF blows whistle on drug cos in U'khand
IN a bold move that could shake the pharmaceutical sector, the All India Chemists and Distributors Federation (AICDF) has submitted a scathing complaint to the National Pharmaceutical Pricing Authority (NPPA), raising serious concerns over the activities of certain drug manufacturers operating out of Uttarakhand.
2 min |
September 25, 2025
Chronicle Pharmabiz
HC appoints team to conduct inspection on Palamur Bio's facility
THE Delhi High Court (HC) has appointed a three-member inspection team to conduct fresh inspection at the facility of Telangana-based preclinical contract research organisation Palamur Biosciences in connection with the allegations raised by the People for the Ethical Treatment of Animals India (PETA India) pertaining to abuse and neglect of animals while carrying out experimentation.
2 min |
September 25, 2025
Chronicle Pharmabiz
Telangana DCA raids quack's clinic in Renga Reddy district
IN a swift action to curb illegal drug sales and protect public health, the Drugs Control Administration (DCA) of Telangana has successfully raided the premises of an unqualified practitioner in the Ranga Reddy District.
2 min |
September 25, 2025
Chronicle Pharmabiz
PCI announces modified time schedule for admission from 2026-27
THE Pharmacy Council of India (PCI) has announced revised time schedule for last date of admission of students, effective from the academic session 2026-27, following a favourable order from the Supreme Court (SC) in tune with a request submitted by the Council in a related matter.
2 min |
September 25, 2025
Chronicle Pharmabiz
Need to advance neuropsychological assessment in AD
NEUROLOGISTS are concerned on the rising rates of Alzheimer's disease (AD) affecting across age-groups. On the occasion of World Alzheimer's Day observed annually on September 21, with the theme as 'Ask About Dementia, Ask About Alzheimer's'.
2 min |
September 25, 2025
Chronicle Pharmabiz
'Digital diagnostics shaping new standards in global treatment protocols'
THE healthcare industry in the country is in the midst of a digital revolution, with diagnostics at the core of this transformation. The shift of digital diagnostics from a supplementary tool to a standard component of global healthcare is already underway, and it is poised to accelerate.
1 min |
September 25, 2025
Chronicle Pharmabiz
DHR invites health research proposals for 2025-26
IN a significant push to advance interdisciplinary health research in India, the Union health ministry, through its Department of Health Research (DHR), has issued a nationwide call for research proposals under the \"Grant-in-aid Scheme for Inter-sectoral Convergence and Coordination for Promotion and Guidance on Health Research\" for the financial year 2025-26.
1 min |
September 25, 2025
Chronicle Pharmabiz
A GST Relief for Patients
THE 56th meeting of the GST Council led by Union Finance Minister Nirmala Sitaraman has recommended reduction of Goods and Services Tax (GST) rate for all drugs and medical devices to 5%, and waiver of GST for 36 lifesaving drugs.
2 min |
September 25, 2025
Chronicle Pharmabiz
GE experiments can approach regulator with IBSC nod: DBT
THE biopharmaceutical manufacturers of products such as vaccines, recombinant DNA, and others, can approach the central drug regulator with the approval of Institutional Biosafety Committee (IBSC) for manufacturing of test items for examination, test and analysis if the test item is generated using lower risk genetic engineering (GE) experiments, rather than taking one more approval from the Review Committee on Genetic Manipulation (RCGM).
2 min |
September 25, 2025
Chronicle Pharmabiz
NPPA extends price fixation on orthopaedics
THE National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for two more months, up to November 15, 2025.
3 min |
September 25, 2025
Chronicle Pharmabiz
CDSCO simplifies online provision for import of medical devices, IVD
THE Central Drugs Standard Organisation (CDSCO) has brought in changes to its online system for approval of medical devices imports in order to simplify and expedite the process for import of medical devices and in-vitro diagnostics (IVD) which are already approved by the Central Licensing Authority CLA.
1 min |
September 25, 2025
Chronicle Pharmabiz
Roche partners with 10 govt hospitals to strengthen trials
ROCHE Pharma India has announced the successful completion of the first phase of its Advanced Inclusive Research (AIR) Site Alliance initiative in India, having partnered with 10 leading government hospitals from across the country and trained nearly 400 professionals including investigators, ethics committee members and support staff to global Good Clinical Practice standards.
2 min |
September 25, 2025
Chronicle Pharmabiz
Otsuka receives CRL on SNDA from US FDA for using Rexulti
OTSUKA Pharmaceutical Co Ltd, (Otsuka) and H. Lundbeck A/S (Lundbeck) announced that Otsuka has received a Complete Response Letter (CRL) from the US FDA regarding the supplemental New Drug Application (SNDA) for use of Rexulti (brexpiprazole) in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD).
1 min |
September 25, 2025
Chronicle Pharmabiz
MSMEs underscore indispensability of compressed air for drug quality
INDIAN Pharma MSMEs are increasingly highlighting the critical role of compressed air systems in maintaining drug quality, safety, and manufacturing efficiency.
2 min |
September 25, 2025
Chronicle Pharmabiz
Dr Akram Ahmad proposes strategy to solve shortage of docs
IN a country where the doctor-to-population ratio is a critical concern, particularly in rural areas, a new proposal is challenging conventional thinking about how to solve India's healthcare workforce shortage.
2 min |